Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00590798 · ClinicalTrials.gov registry record · NA

Star-Close Early Ambulation Trial

A NA study of Cardiovascular Disease, sponsored by Ernest Mazzaferri.

Completed
Registry status
NA
Development phase
58
Enrollment target
1
Study location

NCT00590798 is a NA study of Cardiovascular Disease that has completed, run by Ernest Mazzaferri. The registered enrollment target is 58 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00590798, a NA study of Cardiovascular Disease, has completed, sponsored by Ernest Mazzaferri.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

To confirm that patients who receive the Star-Close vascular closure system (VCS) can safely ambulate within 30 minutes of catheterization.

Conditions Studied

Interventions

  • BEHAVIORAL Walking

Study Locations (1)

Ohio

  • The Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2007-04
Est. Completion 2008-12
Phase NA

Sponsor

Ernest Mazzaferri

1 total trials

What the Registry Record Tells You About NCT00590798

The ClinicalTrials.gov registry entry for NCT00590798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (98% lower). The listed sponsor is Ernest Mazzaferri, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Walking is the first listed.

NCT00590798 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00590798 about?

NCT00590798 is a clinical study titled "Star-Close Early Ambulation Trial". To confirm that patients who receive the Star-Close vascular closure system (VCS) can safely ambulate within 30 minutes of catheterization.

What is the current status of trial NCT00590798?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2007-04. Estimated completion is 2008-12.

What conditions does trial NCT00590798 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

What interventions are being tested in trial NCT00590798?

The interventions under investigation include: Walking (BEHAVIORAL).

Who is sponsoring clinical trial NCT00590798?

This trial is sponsored by Ernest Mazzaferri, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00590798 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.